News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017